These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Comparative analysis of the effectiveness and tolerance of chrysanol and myochrysine in patients with rheumatoid arthritis (preliminary report)]. Slobodina GA Ter Arkh; 1985; 57(7):131-6. PubMed ID: 2931846 [TBL] [Abstract][Full Text] [Related]
26. [A case of "gold lung" in the form of PIE syndrome]. Takiguchi Y; Hashizume I; Kasamatsu N; Shinozaki K; Yasuda J; Hanzawa S; Wada G; Sato N; Kadoyama C; Okamoto K Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Apr; 24(4):459-64. PubMed ID: 3091893 [No Abstract] [Full Text] [Related]
27. Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate. Svensson A; Theander J Ann Rheum Dis; 1992 Mar; 51(3):326-9. PubMed ID: 1533505 [TBL] [Abstract][Full Text] [Related]
28. Forty-seven years experience with gold therapy in 1,019 rheumatoid arthritis patients. Lockie LM; Smith DM Semin Arthritis Rheum; 1985 May; 14(4):238-46. PubMed ID: 2934818 [No Abstract] [Full Text] [Related]
29. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions. Klinefelter J Rheumatol; 1975 Mar; 2(1):21-7. PubMed ID: 127042 [TBL] [Abstract][Full Text] [Related]
30. [Gold therapy in chronic polyarthritis. Differentiation of allergic and toxic side effects]. Bene E; Megyeri A; Györi J Z Rheumatol; 1980; 39(3-4):109-16. PubMed ID: 6448525 [TBL] [Abstract][Full Text] [Related]
31. [Deaths from gold therapy in Denmark during 1960-64]. Iuel J Ugeskr Laeger; 1973 Jul; 135(31):1639-42. PubMed ID: 4271249 [No Abstract] [Full Text] [Related]
32. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety]. Batlle Gualda E Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899 [No Abstract] [Full Text] [Related]
33. [Gold lung]. Lem P Tidsskr Nor Laegeforen; 1980 Sep; 100(25):1486-8. PubMed ID: 6779402 [No Abstract] [Full Text] [Related]
34. Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold. Wilkinson SM; Smith AG; Davis MJ; Mattey D; Dawes PT Ann Rheum Dis; 1992 Jul; 51(7):881-4. PubMed ID: 1385941 [TBL] [Abstract][Full Text] [Related]
35. Hepatitis and neutropenia secondary to gold thiomalate therapy for rheumatoid arthritis. Smith MD Aust N Z J Med; 1986 Feb; 16(1):72-4. PubMed ID: 3085648 [TBL] [Abstract][Full Text] [Related]
36. Gold vs D-penicillamine double blind study and followup. Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537 [TBL] [Abstract][Full Text] [Related]
37. Myelotoxicity of gold. Kay AG Br Med J; 1976 May; 1(6020):1266-8. PubMed ID: 817772 [TBL] [Abstract][Full Text] [Related]
38. Risk factors that may influence development of side effects of gold sodium thiomalate. Kay EA; Jayson MI Scand J Rheumatol; 1987; 16(4):241-5. PubMed ID: 2957787 [TBL] [Abstract][Full Text] [Related]
39. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate. Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585 [TBL] [Abstract][Full Text] [Related]
40. Gold sodium thiomalate for the treatment of rheumatoid arthritis in a patient with hepatitis B. Buckley WA; Stump AL; Monger RM; Lookabill SK Ann Pharmacother; 2011 Apr; 45(4):e23. PubMed ID: 21467262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]